nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—Irritability—Valrubicin—urinary bladder cancer	0.0442	0.0486	CcSEcCtD
Clorazepate—Slurred speech—Fluorouracil—urinary bladder cancer	0.0409	0.045	CcSEcCtD
Clorazepate—Slurred speech—Cisplatin—urinary bladder cancer	0.0388	0.0427	CcSEcCtD
Clorazepate—Midazolam—CYP4B1—urinary bladder cancer	0.0286	0.315	CrCbGaD
Clorazepate—Haematocrit decreased—Methotrexate—urinary bladder cancer	0.0255	0.0281	CcSEcCtD
Clorazepate—Drowsiness—Mitomycin—urinary bladder cancer	0.0246	0.0271	CcSEcCtD
Clorazepate—Dysarthria—Fluorouracil—urinary bladder cancer	0.0193	0.0213	CcSEcCtD
Clorazepate—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0188	0.0206	CcSEcCtD
Clorazepate—Dysarthria—Cisplatin—urinary bladder cancer	0.0183	0.0202	CcSEcCtD
Clorazepate—Vision blurred—Mitomycin—urinary bladder cancer	0.0181	0.0199	CcSEcCtD
Clorazepate—Flurbiprofen—UGT2B7—urinary bladder cancer	0.0179	0.197	CrCbGaD
Clorazepate—Clonazepam—NAT2—urinary bladder cancer	0.0177	0.195	CrCbGaD
Clorazepate—Asthenia—Valrubicin—urinary bladder cancer	0.0163	0.018	CcSEcCtD
Clorazepate—Confusional state—Mitomycin—urinary bladder cancer	0.0158	0.0174	CcSEcCtD
Clorazepate—Ataxia—Thiotepa—urinary bladder cancer	0.0151	0.0166	CcSEcCtD
Clorazepate—Dizziness—Valrubicin—urinary bladder cancer	0.0151	0.0166	CcSEcCtD
Clorazepate—Rash—Valrubicin—urinary bladder cancer	0.0144	0.0158	CcSEcCtD
Clorazepate—Dermatitis—Valrubicin—urinary bladder cancer	0.0143	0.0158	CcSEcCtD
Clorazepate—Headache—Valrubicin—urinary bladder cancer	0.0143	0.0157	CcSEcCtD
Clorazepate—Somnolence—Mitomycin—urinary bladder cancer	0.0139	0.0153	CcSEcCtD
Clorazepate—Fatigue—Mitomycin—urinary bladder cancer	0.0135	0.0149	CcSEcCtD
Clorazepate—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0129	0.0142	CcSEcCtD
Clorazepate—Irritability—Fluorouracil—urinary bladder cancer	0.0127	0.0139	CcSEcCtD
Clorazepate—Ataxia—Fluorouracil—urinary bladder cancer	0.0125	0.0137	CcSEcCtD
Clorazepate—Irritability—Cisplatin—urinary bladder cancer	0.012	0.0132	CcSEcCtD
Clorazepate—Oxazepam—UGT2B7—urinary bladder cancer	0.0119	0.131	CrCbGaD
Clorazepate—Asthenia—Mitomycin—urinary bladder cancer	0.0113	0.0124	CcSEcCtD
Clorazepate—Dizziness—Mitomycin—urinary bladder cancer	0.0104	0.0114	CcSEcCtD
Clorazepate—Dysarthria—Methotrexate—urinary bladder cancer	0.0101	0.0111	CcSEcCtD
Clorazepate—Rash—Mitomycin—urinary bladder cancer	0.00989	0.0109	CcSEcCtD
Clorazepate—Dermatitis—Mitomycin—urinary bladder cancer	0.00988	0.0109	CcSEcCtD
Clorazepate—Headache—Mitomycin—urinary bladder cancer	0.00983	0.0108	CcSEcCtD
Clorazepate—Tension—Thiotepa—urinary bladder cancer	0.00949	0.0104	CcSEcCtD
Clorazepate—Dysarthria—Epirubicin—urinary bladder cancer	0.00941	0.0104	CcSEcCtD
Clorazepate—Nervousness—Thiotepa—urinary bladder cancer	0.00939	0.0103	CcSEcCtD
Clorazepate—Vision blurred—Thiotepa—urinary bladder cancer	0.00911	0.01	CcSEcCtD
Clorazepate—Dysarthria—Doxorubicin—urinary bladder cancer	0.00871	0.00958	CcSEcCtD
Clorazepate—Confusional state—Thiotepa—urinary bladder cancer	0.00796	0.00875	CcSEcCtD
Clorazepate—Vision blurred—Fluorouracil—urinary bladder cancer	0.00754	0.00829	CcSEcCtD
Clorazepate—Vision blurred—Cisplatin—urinary bladder cancer	0.00714	0.00786	CcSEcCtD
Clorazepate—Tremor—Cisplatin—urinary bladder cancer	0.0071	0.00781	CcSEcCtD
Clorazepate—Somnolence—Thiotepa—urinary bladder cancer	0.00701	0.00771	CcSEcCtD
Clorazepate—Fatigue—Thiotepa—urinary bladder cancer	0.0068	0.00748	CcSEcCtD
Clorazepate—Irritability—Methotrexate—urinary bladder cancer	0.00659	0.00725	CcSEcCtD
Clorazepate—Confusional state—Fluorouracil—urinary bladder cancer	0.00658	0.00724	CcSEcCtD
Clorazepate—Feeling abnormal—Thiotepa—urinary bladder cancer	0.0065	0.00715	CcSEcCtD
Clorazepate—Ataxia—Methotrexate—urinary bladder cancer	0.00649	0.00714	CcSEcCtD
Clorazepate—Diplopia—Epirubicin—urinary bladder cancer	0.00646	0.00711	CcSEcCtD
Clorazepate—Fenbufen—PTGS2—urinary bladder cancer	0.00629	0.0693	CrCbGaD
Clorazepate—Ataxia—Epirubicin—urinary bladder cancer	0.00608	0.00668	CcSEcCtD
Clorazepate—Insomnia—Gemcitabine—urinary bladder cancer	0.006	0.0066	CcSEcCtD
Clorazepate—Diplopia—Doxorubicin—urinary bladder cancer	0.00598	0.00658	CcSEcCtD
Clorazepate—Insomnia—Fluorouracil—urinary bladder cancer	0.0059	0.00649	CcSEcCtD
Clorazepate—Somnolence—Gemcitabine—urinary bladder cancer	0.0059	0.00649	CcSEcCtD
Clorazepate—Somnolence—Fluorouracil—urinary bladder cancer	0.0058	0.00638	CcSEcCtD
Clorazepate—Fatigue—Gemcitabine—urinary bladder cancer	0.00572	0.00629	CcSEcCtD
Clorazepate—Confusional state—Etoposide—urinary bladder cancer	0.00571	0.00629	CcSEcCtD
Clorazepate—Asthenia—Thiotepa—urinary bladder cancer	0.00566	0.00623	CcSEcCtD
Clorazepate—Ataxia—Doxorubicin—urinary bladder cancer	0.00562	0.00619	CcSEcCtD
Clorazepate—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00547	0.00602	CcSEcCtD
Clorazepate—Oxaprozin—PTGS2—urinary bladder cancer	0.00547	0.0602	CrCbGaD
Clorazepate—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00538	0.00591	CcSEcCtD
Clorazepate—Drowsiness—Methotrexate—urinary bladder cancer	0.00532	0.00585	CcSEcCtD
Clorazepate—Dizziness—Thiotepa—urinary bladder cancer	0.00522	0.00574	CcSEcCtD
Clorazepate—Feeling abnormal—Cisplatin—urinary bladder cancer	0.0051	0.00561	CcSEcCtD
Clorazepate—Somnolence—Etoposide—urinary bladder cancer	0.00504	0.00554	CcSEcCtD
Clorazepate—Drowsiness—Epirubicin—urinary bladder cancer	0.00498	0.00548	CcSEcCtD
Clorazepate—Rash—Thiotepa—urinary bladder cancer	0.00497	0.00547	CcSEcCtD
Clorazepate—Dermatitis—Thiotepa—urinary bladder cancer	0.00497	0.00547	CcSEcCtD
Clorazepate—Headache—Thiotepa—urinary bladder cancer	0.00494	0.00544	CcSEcCtD
Clorazepate—Fatigue—Etoposide—urinary bladder cancer	0.00489	0.00537	CcSEcCtD
Clorazepate—Asthenia—Gemcitabine—urinary bladder cancer	0.00476	0.00524	CcSEcCtD
Clorazepate—Feeling abnormal—Etoposide—urinary bladder cancer	0.00467	0.00514	CcSEcCtD
Clorazepate—Drowsiness—Doxorubicin—urinary bladder cancer	0.00461	0.00507	CcSEcCtD
Clorazepate—Asthenia—Cisplatin—urinary bladder cancer	0.00444	0.00488	CcSEcCtD
Clorazepate—Dizziness—Fluorouracil—urinary bladder cancer	0.00432	0.00475	CcSEcCtD
Clorazepate—Rash—Gemcitabine—urinary bladder cancer	0.00418	0.0046	CcSEcCtD
Clorazepate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00418	0.0046	CcSEcCtD
Clorazepate—Headache—Gemcitabine—urinary bladder cancer	0.00416	0.00457	CcSEcCtD
Clorazepate—Rash—Fluorouracil—urinary bladder cancer	0.00411	0.00453	CcSEcCtD
Clorazepate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00411	0.00452	CcSEcCtD
Clorazepate—Headache—Fluorouracil—urinary bladder cancer	0.00409	0.0045	CcSEcCtD
Clorazepate—Asthenia—Etoposide—urinary bladder cancer	0.00407	0.00447	CcSEcCtD
Clorazepate—Vision blurred—Methotrexate—urinary bladder cancer	0.00392	0.00431	CcSEcCtD
Clorazepate—Rash—Cisplatin—urinary bladder cancer	0.0039	0.00429	CcSEcCtD
Clorazepate—Dermatitis—Cisplatin—urinary bladder cancer	0.0039	0.00429	CcSEcCtD
Clorazepate—Tension—Epirubicin—urinary bladder cancer	0.00382	0.0042	CcSEcCtD
Clorazepate—Nervousness—Epirubicin—urinary bladder cancer	0.00378	0.00416	CcSEcCtD
Clorazepate—Dizziness—Etoposide—urinary bladder cancer	0.00375	0.00412	CcSEcCtD
Clorazepate—Vision blurred—Epirubicin—urinary bladder cancer	0.00367	0.00403	CcSEcCtD
Clorazepate—Rash—Etoposide—urinary bladder cancer	0.00357	0.00393	CcSEcCtD
Clorazepate—Dermatitis—Etoposide—urinary bladder cancer	0.00357	0.00393	CcSEcCtD
Clorazepate—Headache—Etoposide—urinary bladder cancer	0.00355	0.00391	CcSEcCtD
Clorazepate—Tension—Doxorubicin—urinary bladder cancer	0.00353	0.00389	CcSEcCtD
Clorazepate—Nervousness—Doxorubicin—urinary bladder cancer	0.0035	0.00385	CcSEcCtD
Clorazepate—Confusional state—Methotrexate—urinary bladder cancer	0.00342	0.00376	CcSEcCtD
Clorazepate—Vision blurred—Doxorubicin—urinary bladder cancer	0.00339	0.00373	CcSEcCtD
Clorazepate—Dry mouth—Epirubicin—urinary bladder cancer	0.00324	0.00356	CcSEcCtD
Clorazepate—Confusional state—Epirubicin—urinary bladder cancer	0.0032	0.00352	CcSEcCtD
Clorazepate—Insomnia—Methotrexate—urinary bladder cancer	0.00307	0.00338	CcSEcCtD
Clorazepate—Somnolence—Methotrexate—urinary bladder cancer	0.00302	0.00332	CcSEcCtD
Clorazepate—Dry mouth—Doxorubicin—urinary bladder cancer	0.003	0.0033	CcSEcCtD
Clorazepate—Confusional state—Doxorubicin—urinary bladder cancer	0.00296	0.00326	CcSEcCtD
Clorazepate—Flurbiprofen—PTGS2—urinary bladder cancer	0.00295	0.0325	CrCbGaD
Clorazepate—Fatigue—Methotrexate—urinary bladder cancer	0.00293	0.00322	CcSEcCtD
Clorazepate—Insomnia—Epirubicin—urinary bladder cancer	0.00287	0.00316	CcSEcCtD
Clorazepate—Somnolence—Epirubicin—urinary bladder cancer	0.00282	0.00311	CcSEcCtD
Clorazepate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.0028	0.00308	CcSEcCtD
Clorazepate—Fatigue—Epirubicin—urinary bladder cancer	0.00274	0.00301	CcSEcCtD
Clorazepate—Insomnia—Doxorubicin—urinary bladder cancer	0.00266	0.00292	CcSEcCtD
Clorazepate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00262	0.00288	CcSEcCtD
Clorazepate—Somnolence—Doxorubicin—urinary bladder cancer	0.00261	0.00287	CcSEcCtD
Clorazepate—Fatigue—Doxorubicin—urinary bladder cancer	0.00253	0.00279	CcSEcCtD
Clorazepate—Asthenia—Methotrexate—urinary bladder cancer	0.00244	0.00268	CcSEcCtD
Clorazepate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00242	0.00266	CcSEcCtD
Clorazepate—Asthenia—Epirubicin—urinary bladder cancer	0.00228	0.00251	CcSEcCtD
Clorazepate—Dizziness—Methotrexate—urinary bladder cancer	0.00224	0.00247	CcSEcCtD
Clorazepate—Rash—Methotrexate—urinary bladder cancer	0.00214	0.00235	CcSEcCtD
Clorazepate—Dermatitis—Methotrexate—urinary bladder cancer	0.00214	0.00235	CcSEcCtD
Clorazepate—Headache—Methotrexate—urinary bladder cancer	0.00213	0.00234	CcSEcCtD
Clorazepate—Asthenia—Doxorubicin—urinary bladder cancer	0.00211	0.00232	CcSEcCtD
Clorazepate—Dizziness—Epirubicin—urinary bladder cancer	0.0021	0.00231	CcSEcCtD
Clorazepate—Rash—Epirubicin—urinary bladder cancer	0.002	0.0022	CcSEcCtD
Clorazepate—Dermatitis—Epirubicin—urinary bladder cancer	0.002	0.0022	CcSEcCtD
Clorazepate—Headache—Epirubicin—urinary bladder cancer	0.00199	0.00219	CcSEcCtD
Clorazepate—Dizziness—Doxorubicin—urinary bladder cancer	0.00194	0.00214	CcSEcCtD
Clorazepate—Rash—Doxorubicin—urinary bladder cancer	0.00185	0.00204	CcSEcCtD
Clorazepate—Dermatitis—Doxorubicin—urinary bladder cancer	0.00185	0.00204	CcSEcCtD
Clorazepate—Headache—Doxorubicin—urinary bladder cancer	0.00184	0.00203	CcSEcCtD
